How These Healthcare Stocks are Performing? -- AMAG Pharma, IDEXX Laboratories, Neogenomics, and ICON
PR Newswire - Fri Jul 29, 7:50AM CDT
The Healthcare sector remains one of the most stable industries in the market, unfazed by economic conditions and uncertainties. While the industry faces issues with cost pressures, ransomware risks, and existing policies, several companies remain unscathed and continue to impress with significant returns. Stocks to evaluate today on Stock-Callers.com are AMAG Pharmaceuticals Inc. (NASDAQ: AMAG), IDEXX Laboratories Inc. (NASDAQ: IDXX), Neogenomics Inc. (NASDAQ: NEO), and ICON PLC (NASDAQ: ICLR). Learn more about these stocks by accessing their free notes at:
NEO: 7.95 (-0.09), AMAG: 23.71 (-0.12), IDXX: 113.16 (+0.48), ICLR: 76.85 (+0.06)
Fate Therapeutics (FATE) Catches Eye: Stock Jumps 19.1%
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 7:25AM CDT
Fate Therapeutics, Inc. (FATE) moved big last session, as its shares jumped over 19% on the day.
FATE: 2.45 (-0.15), NEO: 7.95 (-0.09)
Zacks Investment Ideas feature highlights: Neogenomics, AMN Healthcare Services, Glaukos, National Commerce and NMI Holdings
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:30AM CDT
Zacks Investment Ideas feature highlights: Neogenomics, AMN Healthcare Services, Glaukos, National Commerce and NMI Holdings
GKOS: 30.07 (+0.23), NEO: 7.95 (-0.09), NCOM: 27.25 (+0.33), AHS: 35.68 (-0.55)
5 Great Growth Stocks To Buy Now
Brian Bolan - ZACKS - Fri Jun 17, 12:57PM CDT
5 Great Growth Stocks To Buy Now
GKOS: 30.07 (+0.23), NEO: 7.95 (-0.09), NCOM: 27.25 (+0.33), AHS: 35.68 (-0.55), NMIH: 7.98 (+0.04)
Zacks.com featured highlights: United Natural Foods, Weight Watchers International, PharMerica, Boardwalk Pipeline Partners and Neogenomics
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 8:30AM CDT
Zacks.com featured highlights: United Natural Foods, Weight Watchers International, PharMerica, Boardwalk Pipeline Partners and Neogenomics
PMC: 25.19 (-0.07), UNFI: 45.08 (-0.52), NEO: 7.95 (-0.09), BWP: 16.34 (+0.11), WTW: 10.26 (-0.25)
Bet on These 5 Stocks with Upgraded Broker Ratings
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 8:14AM CDT
After thorough research, brokers decide to rate that particular company's stock. Naturally, when an analyst upgrades a stock, you can easily rely on it.
PMC: 25.19 (-0.07), UNFI: 45.08 (-0.52), NEO: 7.95 (-0.09), BWP: 16.34 (+0.11), WTW: 10.26 (-0.25)
Neogenomics (NEO) Sees Hammer Chart Pattern: Time to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 8:54AM CDT
Neogenomics Inc. (NEO) has been struggling lately, but the selling pressure may be coming to an end soon
NEO: 7.95 (-0.09)
Zacks.com featured expert Kevin Matras highlights: Commercial Vehicle Group, Neogenomics and NetEase
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 8:30AM CDT
Zacks.com featured expert Kevin Matras highlights: Commercial Vehicle Group, Neogenomics and NetEase
NTES: 215.91 (+3.94), NEO: 7.95 (-0.09), CVGI: 5.42 (+0.03)
Explosive Returns with the Filtered Zacks Rank 5 Strategy
Kevin Matras - ZACKS - Tue Jun 07, 3:38PM CDT
Explosive Returns with the Filtered Zacks Rank 5 Strategy
NTES: 215.91 (+3.94), NEO: 7.95 (-0.09), CVGI: 5.42 (+0.03)
Bet on These 5 Liquid Stocks for Fat Returns
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 12:23PM CDT
An efficient company with a favorable liquidity level may prove to be a profitable addition to one's portfolio.
NEO: 7.95 (-0.09), SLAB: 57.66 (+0.36), NTGR: 57.17 (+0.17), LPLA: 29.39 (-0.34), AMPH: 18.99 (-0.01)
The Zacks Analyst Blog Highlights: Health Insurance Innovations, AMN Healthcare Services, Neogenomics, Amerisafe and CoStar Group
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 8:30AM CDT
The Zacks Analyst Blog Highlights: Health Insurance Innovations, AMN Healthcare Services, Neogenomics, Amerisafe and CoStar Group
CSGP: 210.08 (+2.83), AMSF: 59.78 (-0.23), NEO: 7.95 (-0.09), HIIQ: 5.57 (-0.15), AHS: 35.68 (-0.55)
7 Stocks with Recent Price Strength to Boost Your Returns
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 9:24AM CDT
Stocks that have recently seen price strength have high chances of carrying the momentum forward.
AMSF: 59.78 (-0.23), NEO: 7.95 (-0.09), HIIQ: 5.57 (-0.15), AHS: 35.68 (-0.55), COHR: 106.11 (+0.93), NANO: 20.59 (+0.25)
Integra (IART): Strong Revenue Growth on Global Prospects
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 7:16AM CDT
On May 31, 2016, we issued an updated research report on Plainsboro, NJ-based Integra LifeSciences Holdings Corporation (IART).
IART: 86.78 (+0.36), ANIP: 61.42 (+1.68), NEO: 7.95 (-0.09), RTRX: 16.35 (+0.33)
Earnings Estimates Moving Higher for Neogenomics (NEO): Time to Buy?
Zacks Equity Research - Zacks Investment Research - Thu May 26, 7:42AM CDT
Neogenomics (NEO) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision.
NEO: 7.95 (-0.09)
Integra Unveils Fin-Lock Glenoid, Boosts Shoulder Arthroplasty
Zacks Equity Research - Zacks Investment Research - Tue May 24, 7:22AM CDT
Integra LifeSciences Holdings Corporation (IART) recently launched Integra Fin-Lock Glenoid.
IART: 86.78 (+0.36), HSKA: 52.76 (-1.81), ANIP: 61.42 (+1.68), NEO: 7.95 (-0.09)
NeoGenomics Reports 159% Revenue growth to $59.7 Million and 442% Adjusted EBITDA increase to $8.2 Million, Driven by Clarient acquisition and Strong Volume Gains
PR Newswire - Wed Apr 27, 6:00AM CDT
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the first quarter of 2016.
NEO: 7.95 (-0.09)
Investor Calendar Invites You to the NeoGenomics First Quarter 2016 Earnings Conference Call and Webcast Live on Wednesday April 27, 2016
ACCESSWIRE - Tue Apr 26, 3:05PM CDT
FORT MYERS, FL / ACCESSWIRE / April 26, 2016 / NeoGenomics, Inc. (NASDAQ: NEO) will host a conference call and live webcast to discuss the results of the first quarter 2016, to be held Wednesday, April 27, 2016 at 11:00 AM Eastern Time.
NEO: 7.95 (-0.09)
NeoGenomics Schedules its Q1 2016 Earnings Release for April 27, 2016
PR Newswire - Mon Apr 11, 6:00AM CDT
NeoGenomics, Inc. (NASDAQ: NEO) announced today that it plans to release its first quarter 2016 financial results on Wednesday April 27, 2016.
NEO: 7.95 (-0.09)